Download PDF
Thromb Haemost 2019; 119(12): 2053-2063
DOI: 10.1055/s-0039-1697663
Stroke, Systemic or Venous Thromboembolism
Georg Thieme Verlag KG Stuttgart · New York

Dietary Intake of Marine Polyunsaturated n-3 Fatty Acids and Risk of Recurrent Venous Thromboembolism

Trond Isaksen
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT-The Arctic University of Norway, Tromsø, Norway
2   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
Line H. Evensen
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT-The Arctic University of Norway, Tromsø, Norway
2   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
Sigrid K. Brækkan
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT-The Arctic University of Norway, Tromsø, Norway
2   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
,
John-Bjarne Hansen
1   Department of Clinical Medicine, K.G. Jebsen Thrombosis Research and Expertise Center (TREC), UiT-The Arctic University of Norway, Tromsø, Norway
2   Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
› Author Affiliations Funding The K.G. Jebsen-Thrombosis Research and Expertise Center is supported by an independent grant from Stiftelsen Kristian Gerhard Jebsen.
Further Information

Publication History

07 May 2019

15 August 2019

Publication Date:
28 October 2019 (online)

    Permissions and Reprints

Abstract

Background Limited knowledge exists on the association between intake of long-chained n-3 polyunsaturated fatty acids (n-3 PUFAs) and risk of recurrence and all-cause mortality in patients with venous thromboembolism (VTE).

Objectives This article investigates whether intake of marine n-3 PUFAs was associated with risk of recurrence and mortality in patients with incident VTE.

Methods A total of 595 patients with incident VTE and available data on n-3 PUFA intake were derived from the Tromsø Study surveys 4 (1994–1995) and 6 (2007–2008). Weekly intake of n-3 PUFAs was categorized as low, medium, and high based on tertiles. Recurrent VTEs and all-cause mortality were registered up to December 31, 2016. Hazard ratios (HRs) were calculated using Cox regression models with the low intake category as reference.

Results There were 98 recurrent VTEs and 227 deaths during follow-up. Overall, we found no association between intake of n-3 PUFAs and risk of recurrent VTE. However, inverse associations were found for high intakes in patients with unprovoked VTE (HR 0.45, 95% confidence interval [CI]: 0.20–1.01), cancer-free patients (HR 0.51, 95% CI: 0.27–0.95), and deep vein thrombosis (DVT) patients (HR 0.49, 95% CI: 0.24–0.97). The inverse associations were more evident when follow-up was restricted to the time after discontinuation of anticoagulant therapy. No association was observed between intake of n-3 PUFAs and mortality after incident VTE.

Conclusion A high dietary intake of marine n-3 PUFAs was associated with lower risk of recurrent VTE after unprovoked index events, DVT, and in cancer-free patients.

Keywords

diet - omega-3 fatty acids - recurrence - risk factors - venous thromboembolism

Supplementary Material

 

  • References

  • 1 Cohen AT, Agnelli G, Anderson FA. , et al; VTE Impact Assessment Group in Europe (VITAE). Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98 (04) 756-764
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (23) (Suppl. 01) I22-I30
    PubMedGoogle Scholar
  • 3 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (04) 692-699
    CrossrefPubMedGoogle Scholar
  • 4 Arshad N, Bjøri E, Hindberg K, Isaksen T, Hansen JB, Braekkan SK. Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemost 2017; 15 (02) 295-303
    CrossrefPubMedGoogle Scholar
  • 5 Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton III LJ. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000; 160 (06) 761-768
    CrossrefPubMedGoogle Scholar
  • 6 Prandoni P, Lensing AW, Cogo A. , et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125 (01) 1-7
    PubMedGoogle Scholar
  • 7 Søgaard KK, Schmidt M, Pedersen L, Horváth-Puhó E, Sørensen HT. 30-year mortality after venous thromboembolism: a population-based cohort study. Circulation 2014; 130 (10) 829-836
    CrossrefPubMedGoogle Scholar
  • 8 Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA. ; Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 2016; 14 (07) 1480-1483
    CrossrefPubMedGoogle Scholar
  • 9 Kearon C, Akl EA, Ornelas J. , et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149 (02) 315-352
    CrossrefPubMedGoogle Scholar
  • 10 Heit JA, Lahr BD, Petterson TM, Bailey KR, Ashrani AA, Melton III LJ. Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study. Blood 2011; 118 (18) 4992-4999
    PubMedGoogle Scholar
  • 11 The Norwegian Directorate of Health. Kostråd om fisk og sjømat (Dietary advice on fish and seafood). Available at: https://helsenorge.no/kosthold-og-ernaring/kostrad/spis-fisk-oftere . Accessed June 22, 2019
    PubMedGoogle Scholar
  • 12 U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans. 8th ed. Available at: https://health.gov/dietaryguidelines/2015/guidelines/ . Accessed June 22, 2018
    PubMedGoogle Scholar
  • 13 Rimm EB, Appel LJ, Chiuve SE. , et al; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: a science advisory from the American Heart Association. Circulation 2018; 138 (01) e35-e47
    PubMedGoogle Scholar
  • 14 Surette ME. The science behind dietary omega-3 fatty acids. CMAJ 2008; 178 (02) 177-180
    CrossrefPubMedGoogle Scholar
  • 15 Hansen JB, Olsen JO, Wilsgård L, Lyngmo V, Svensson B. Comparative effects of prolonged intake of highly purified fish oils as ethyl ester or triglyceride on lipids, haemostasis and platelet function in normolipaemic men. Eur J Clin Nutr 1993; 47 (07) 497-507
    PubMedGoogle Scholar
  • 16 Hansen JB, Svensson B, Wilsgård L, Osterud B. Serum enriched with n-3 polyunsaturated fatty acids inhibits procoagulant activity in endothelial cells. Blood Coagul Fibrinolysis 1991; 2 (04) 515-519
    CrossrefPubMedGoogle Scholar
  • 17 De Caterina R, Cybulsky MA, Clinton SK, Gimbrone Jr MA, Libby P. Omega-3 fatty acids and endothelial leukocyte adhesion molecules. Prostaglandins Leukot Essent Fatty Acids 1995; 52 (2-3): 191-195
    CrossrefPubMedGoogle Scholar
  • 18 Moertl D, Berger R, Hammer A. , et al. Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure. Thromb Haemost 2011; 106 (03) 457-465
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Hansen-Krone IJ, Enga KF, Südduth-Klinger JM. , et al. High fish plus fish oil intake is associated with slightly reduced risk of venous thromboembolism: the Tromsø Study. J Nutr 2014; 144 (06) 861-867
    CrossrefPubMedGoogle Scholar
  • 20 Severinsen MT, Overvad K, Andersen VL, Tjønneland A, Schmidt EB, Kristensen SR. Fish intake and venous thromboembolism: a Danish follow-up study. Thromb Res 2014; 133 (03) 352-356
    CrossrefPubMedGoogle Scholar
  • 21 Steffen LM, Folsom AR, Cushman M, Jacobs Jr DR, Rosamond WD. Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation 2007; 115 (02) 188-195
    CrossrefPubMedGoogle Scholar
  • 22 Isaksen T, Evensen LH, Johnsen SH. , et al. Dietary intake of marine n-3 polyunsaturated fatty acids and future risk of venous thromboembolism. Res Pract Thromb Haemost 2018; 3 (01) 59-69
    PubMedGoogle Scholar
  • 23 Reiner MF, Stivala S, Limacher A. , et al. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism. J Thromb Haemost 2017; 15 (01) 47-56
    CrossrefPubMedGoogle Scholar
  • 24 Sarkkinen ES, Agren JJ, Ahola I, Ovaskainen ML, Uusitupa MI. Fatty acid composition of serum cholesterol esters, and erythrocyte and platelet membranes as indicators of long-term adherence to fat-modified diets. Am J Clin Nutr 1994; 59 (02) 364-370
    CrossrefPubMedGoogle Scholar
  • 25 Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54 (03) 438-463
    CrossrefPubMedGoogle Scholar
  • 26 Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njølstad I. Cohort profile: the Tromso Study. Int J Epidemiol 2012; 41 (04) 961-967
    CrossrefPubMedGoogle Scholar
  • 27 Braekkan SK, Mathiesen EB, Njølstad I, Wilsgaard T, Størmer J, Hansen JB. Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromsø study. J Thromb Haemost 2008; 6 (11) 1851-1857
    CrossrefPubMedGoogle Scholar
  • 28 Jacobsen BK, Nilsen H. High education is associated with low fat and high fibre, beta-carotene and vitamin C. Computation of nutrient intake based on a short food frequency questionnaire in 17,256 men and women in the Tromsø Study. Nor Epidemiol 2000; 10: 57-62
    PubMedGoogle Scholar
  • 29 Institute of Marine Research. Seafood data. Available at: https://www.nifes.no/ . Accessed August 17, 2018
    PubMedGoogle Scholar
  • 30 Norwegian Food Safety Authority. Matvaretabellen 2018 (Table of food composition 2018). Available at: http://www.matvaretabellen.no/ . Accessed August 17, 2018
    PubMedGoogle Scholar
  • 31 Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509
    CrossrefPubMedGoogle Scholar
  • 32 Hansen JB, Olsen JO, Wilsgård L, Osterud B. Effects of dietary supplementation with cod liver oil on monocyte thromboplastin synthesis, coagulation and fibrinolysis. J Intern Med Suppl 1989; 731: 133-139
    PubMedGoogle Scholar
  • 33 Vanschoonbeek K, Wouters K, van der Meijden PE. , et al. Anticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in mice. Arterioscler Thromb Vasc Biol 2008; 28 (11) 2023-2029
    CrossrefPubMedGoogle Scholar
  • 34 Aung T, Halsey J, Kromhout D. , et al; Omega-3 Treatment Trialists' Collaboration. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol 2018; 3 (03) 225-234
    CrossrefPubMedGoogle Scholar
  • 35 Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011; 58 (20) 2047-2067
    CrossrefPubMedGoogle Scholar
  • 36 Sala-Vila A, Guasch-Ferré M, Hu FB. , et al; PREDIMED Investigators. Dietary α-linolenic acid, marine ω-3 fatty acids, and mortality in a population with high fish consumption: findings from the PREvención con DIeta MEDiterránea (PREDIMED) Study. J Am Heart Assoc 2016; 5 (01) 5
    PubMedGoogle Scholar
  • 37 Pan A, Chen M, Chowdhury R. , et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 2012; 96 (06) 1262-1273
    CrossrefPubMedGoogle Scholar
  • 38 Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353 (9159): 1167-1173
    CrossrefPubMedGoogle Scholar
  • 39 Alexander DD, Miller PE, Van Elswyk ME, Kuratko CN, Bylsma LC. A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clin Proc 2017; 92 (01) 15-29
    CrossrefPubMedGoogle Scholar
  • 40 Mozaffarian D, Lemaitre RN, King IB. , et al. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 2013; 158 (07) 515-525
    CrossrefPubMedGoogle Scholar
  • 41 Flinterman LE, van Hylckama Vlieg A, Cannegieter SC, Rosendaal FR. Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med 2012; 9 (01) e1001155
    CrossrefPubMedGoogle Scholar
  • 42 Faller N, Limacher A, Méan M. , et al. Predictors and causes of long-term mortality in elderly patients with acute venous thromboembolism: a prospective cohort study. Am J Med 2017; 130 (02) 198-206
    CrossrefPubMedGoogle Scholar
  • 43 von Schacky C. Omega-3 fatty acids in cardiovascular disease--an uphill battle. Prostaglandins Leukot Essent Fatty Acids 2015; 92: 41-47
    CrossrefPubMedGoogle Scholar